BiondVax Pharmaceuticals Ltd (NASDAQ:BVXV)

3.21
Delayed Data
As of 3:49pm ET
 +0.02 / +0.63%
Today’s Change
2.35
Today|||52-Week Range
62.00
-65.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$37.9M

Company Description

BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Jerusalem, Israel.

Contact Information

BiondVax Pharmaceuticals Ltd.
Jerusalem BioPark
Jerusalem Jerusalem 74036
P:9723029302529
Investor Relations:
9728

Employees

Shareholders

Other institutional0.91%
Mutual fund holders0.43%
Individual stakeholders--

Top Executives

Ronald BabecoffPresident, Chief Executive Officer & Director
Elad MarkChief Operating Officer
Uri Ben-OrChief Financial Officer
Tamar Ben-YedidiaChief Scientific Officer
Shai AshkenaziMedical Director